Immediate Impact
2 from Science/Nature 60 standout
Citing Papers
Artificial intelligence in drug development
2025 Standout
Therapeutic strategies for COVID-19: progress and lessons learned
2023 Standout
Works of Jiro Wada being referenced
MERS-CoV pathogenesis and antiviral efficacy of licensed drugs in human monocyte-derived antigen-presenting cells
2018
Middle East respiratory syndrome: obstacles and prospects for vaccine development
2015
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Jiro Wada | 293 | 64 | 44 | 72 | 23 | 375 | |
| Changqiang Zhu | 305 | 48 | 92 | 38 | 28 | 424 | |
| Lele Ai | 311 | 42 | 92 | 38 | 27 | 423 | |
| Deepak Sumbria | 134 | 66 | 24 | 92 | 32 | 399 | |
| Mark Anthony B. Casel | 386 | 42 | 25 | 101 | 17 | 455 | |
| Engin Berber | 238 | 78 | 19 | 53 | 27 | 401 | |
| Shilpi Jain | 147 | 43 | 11 | 51 | 38 | 375 | |
| Josilene Nascimento Seixas | 247 | 63 | 30 | 57 | 27 | 400 | |
| Yu Cong | 252 | 59 | 12 | 163 | 18 | 359 | |
| Olivier Escaffre | 217 | 47 | 28 | 265 | 19 | 407 | |
| Huanyu Wu | 206 | 25 | 21 | 154 | 39 | 411 |
All Works
Login with ORCID to disown or claim papers
Loading papers...